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Background
L-Gulonolactone oxidase-deficient mice (Gulo(−/−)) were
used to study the effects of ascorbate deficiency on aortic
relaxation and lowering of blood pressure by nitroglycerin
(GTN). Special emphasis was given to changes in expres-
sion and activity of vascular aldehyde dehydrogenase-2
(ALDH2), which has been recently characterized as key
enzyme of vascular GTN bioactivation.
Methods
Ascorbate deficiency was induced in Gulo(−/−) mice by
ascorbate deprivation for 4 weeks. Some of the animals
were concomitantly treated with the proteasome inhibitor
bortezomib and effects were compared with ascorbate-
supplemented Gulo(−/−), untreated or nitrate-tolerant
wild-type mice. Aortic relaxation of the experimental
groups to GTN, acetylcholine and the NO donor diethyla-
mine NONOate was studied. Changes in mRNA and pro-
tein expression of vascular ALDH2 were quantified by
real-time PCR and immunoblotting, respectively, and aor-
tic GTN denitration rates were determined by thin layer
chromatography. Ubiquitination of proteins was analyzed
by immunoblotting.
Results
Like GTN treatment, ascorbate deprivation induced vascu-
lar tolerance to GTN that was associated with markedly
decreased rates of GTN denitration. Ascorbate deficiency
did not affect ALDH2 mRNA levels, but reduced ALDH2
protein expression and the total amount of ubiquitinated
proteins to about 40% of wild-type controls. These effects
were largely prevented by ascorbate supplementation or
treating Gulo(−/−) mice with the 26S proteasome inhibitor
bortezomib.
Conclusions
Our data indicate that ascorbate deficiency results in vas-
cular tolerance to GTN via proteasomal degradation of
ALDH2. The results support the view that impaired
ALDH2-catalyzed metabolism of GTN contributes signifi-
cantly to the development of vascular nitrate tolerance
and reveal a hitherto unrecognized protective effect of
ascorbate in the vasculature.
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